Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 926 - 950 of 2,573

«
1
…
36
37
38
39
40
…
103
»

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

By: Belisario Arango, MD

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

By: Belisario Arango, MD

Overcoming T-Cell Exhaustion

Overcoming T-Cell Exhaustion

By: Brian S. Henick, MD

Overcoming T-Cell Exhaustion

Overcoming T-Cell Exhaustion

By: Brian S. Henick, MD

New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

By: Bruna Pellini, MD

New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

By: Bruna Pellini, MD

Combined Angio-CT system – Precision therapy in IO

Combined Angio-CT system – Precision therapy in IO

By: Bruno Odisio, MD

Precision Imaging in IO

Precision Imaging in IO

By: Chiara Floridi, MD

Novel Frontiers in the Use of ctDNA in Oncology

Novel Frontiers in the Use of ctDNA in Oncology

By: Christian Rolfo, MD, PhD, MBA, Dr.hc

Biomarkers for Perioperative Immunotherapy?

Biomarkers for Perioperative Immunotherapy?

By: David Carbone, MD

The New Role of Microbiome in Lung Cancer Immunotherapy

The New Role of Microbiome in Lung Cancer Immunotherapy

By: David Carbone, MD

Biomarkers for Perioperative Immunotherapy?

Biomarkers for Perioperative Immunotherapy?

By: David Carbone, MD

The New Role of Microbiome in Lung Cancer Immunotherapy

The New Role of Microbiome in Lung Cancer Immunotherapy

By: David Carbone, MD

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

By: David Gandara, MD

Immunotherapy in Kidney & Bladder Cancers

Immunotherapy in Kidney & Bladder Cancers

By: David I. Quinn, MBBS, PhD, FRACP, FACP

Management of Immune Related Adverse Events

Management of Immune Related Adverse Events

By: Elizabeth (Liz) Cooke, RN, NP, PhD

Management of Immune Related Adverse Events

Management of Immune Related Adverse Events

By: Elizabeth (Liz) Cooke, RN, NP, PhD

Advances in Car-T Cells and Other Cellular Based Therapies

Advances in Car-T Cells and Other Cellular Based Therapies

By: Elizabeth Budde, MD, PhD

Advances in Car-T Cells and Other Cellular Based Therapies

Advances in Car-T Cells and Other Cellular Based Therapies

By: Elizabeth Budde, MD, PhD

Case Study Immunotherapy

Case Study Immunotherapy

By: Gandara, David, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

By: Gerardo Colon-Otero, MD

Immunotherapy and HER2 Targeted Updates in Esophageal Cancer

Immunotherapy and HER2 Targeted Updates in Esophageal Cancer

By: Harry H. Yoon, MD, MHS

Adjuvant/Neo-adjuvant Systemic Therapy

Adjuvant/Neo-adjuvant Systemic Therapy

By: Heather Wakelee, MD

Adjuvant/Neo-Adjuvant Systemic Therapy

Adjuvant/Neo-Adjuvant Systemic Therapy

By: Heather Wakelee, MD

«
1
…
36
37
38
39
40
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok